vs
Karat Packaging Inc.（KRT）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Karat Packaging Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$115.6M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 13.7%），Karat Packaging Inc.自由现金流更多（$15.1M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 10.0%）
Karat Packaging Inc.是专业一次性餐饮包装产品生产商及分销商，产品涵盖纸塑杯、食品容器、餐具、杯盖及定制品牌包装方案，主要服务北美地区的连锁餐厅、咖啡馆、餐饮服务商及零售食品客户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
KRT vs PBYI — 直观对比
营收规模更大
KRT
是对方的1.5倍
$75.5M
营收增速更快
PBYI
高出14.0%
13.7%
自由现金流更多
KRT
多$738.0K
$14.4M
两年增速更快
PBYI
近两年复合增速
10.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.6M | $75.5M |
| 净利润 | $6.8M | — |
| 毛利率 | 34.0% | 69.3% |
| 营业利润率 | 7.3% | 22.7% |
| 净利率 | 5.9% | — |
| 营收同比 | 13.7% | 27.7% |
| 净利润同比 | 21.3% | — |
| 每股收益（稀释后） | $0.34 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRTPBYI
| Q4 25 | $115.6M | $75.5M | ||
| Q3 25 | $124.5M | $54.5M | ||
| Q2 25 | $124.0M | $52.4M | ||
| Q1 25 | $103.6M | $46.0M | ||
| Q4 24 | $101.6M | $59.1M | ||
| Q3 24 | $112.8M | $80.5M | ||
| Q2 24 | $112.6M | $47.1M | ||
| Q1 24 | $95.6M | $43.8M |
净利润KRTPBYI
| Q4 25 | $6.8M | — | ||
| Q3 25 | $7.3M | $8.8M | ||
| Q2 25 | $10.9M | $5.9M | ||
| Q1 25 | $6.4M | $3.0M | ||
| Q4 24 | $5.6M | — | ||
| Q3 24 | $9.1M | $20.3M | ||
| Q2 24 | $9.1M | $-4.5M | ||
| Q1 24 | $6.2M | $-4.8M |
毛利率KRTPBYI
| Q4 25 | 34.0% | 69.3% | ||
| Q3 25 | 34.5% | 77.7% | ||
| Q2 25 | 39.6% | 76.5% | ||
| Q1 25 | 39.3% | 77.1% | ||
| Q4 24 | 39.2% | 76.4% | ||
| Q3 24 | 38.6% | 63.9% | ||
| Q2 24 | 38.5% | 77.4% | ||
| Q1 24 | 39.3% | 75.5% |
营业利润率KRTPBYI
| Q4 25 | 7.3% | 22.7% | ||
| Q3 25 | 6.9% | 17.6% | ||
| Q2 25 | 13.3% | 12.7% | ||
| Q1 25 | 7.5% | 8.7% | ||
| Q4 24 | 7.2% | 22.6% | ||
| Q3 24 | 10.0% | 27.4% | ||
| Q2 24 | 9.9% | -4.6% | ||
| Q1 24 | 8.4% | -5.3% |
净利率KRTPBYI
| Q4 25 | 5.9% | — | ||
| Q3 25 | 5.9% | 16.2% | ||
| Q2 25 | 8.8% | 11.2% | ||
| Q1 25 | 6.2% | 6.5% | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 8.1% | 25.2% | ||
| Q2 24 | 8.1% | -9.6% | ||
| Q1 24 | 6.4% | -11.0% |
每股收益（稀释后）KRTPBYI
| Q4 25 | $0.34 | $0.26 | ||
| Q3 25 | $0.36 | $0.17 | ||
| Q2 25 | $0.54 | $0.12 | ||
| Q1 25 | $0.32 | $0.06 | ||
| Q4 24 | $0.28 | $0.40 | ||
| Q3 24 | $0.45 | $0.41 | ||
| Q2 24 | $0.45 | $-0.09 | ||
| Q1 24 | $0.31 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.9M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $149.4M | $130.3M |
| 总资产 | $287.7M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资KRTPBYI
| Q4 25 | $37.9M | $97.5M | ||
| Q3 25 | $44.0M | $94.4M | ||
| Q2 25 | $57.0M | $96.0M | ||
| Q1 25 | $56.3M | $93.2M | ||
| Q4 24 | $59.9M | $101.0M | ||
| Q3 24 | $60.4M | $96.7M | ||
| Q2 24 | $52.1M | $96.8M | ||
| Q1 24 | $46.7M | $107.2M |
总债务KRTPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益KRTPBYI
| Q4 25 | $149.4M | $130.3M | ||
| Q3 25 | $154.5M | $115.3M | ||
| Q2 25 | $155.8M | $104.7M | ||
| Q1 25 | $153.3M | $97.1M | ||
| Q4 24 | $155.6M | $92.1M | ||
| Q3 24 | $157.3M | $71.1M | ||
| Q2 24 | $157.7M | $48.5M | ||
| Q1 24 | $154.4M | $51.0M |
总资产KRTPBYI
| Q4 25 | $287.7M | $216.3M | ||
| Q3 25 | $302.8M | $202.9M | ||
| Q2 25 | $321.0M | $194.9M | ||
| Q1 25 | $312.2M | $196.2M | ||
| Q4 24 | $294.5M | $213.3M | ||
| Q3 24 | $306.8M | $220.7M | ||
| Q2 24 | $310.7M | $205.0M | ||
| Q1 24 | $279.0M | $214.1M |
负债/权益比KRTPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $15.1M | $14.4M |
| 自由现金流率自由现金流/营收 | 13.1% | 19.1% |
| 资本支出强度资本支出/营收 | 0.2% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.26× | — |
| 过去12个月自由现金流最近4个季度 | $33.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流KRTPBYI
| Q4 25 | $15.4M | $14.4M | ||
| Q3 25 | $982.0K | $9.7M | ||
| Q2 25 | $9.8M | $14.1M | ||
| Q1 25 | $7.7M | $3.6M | ||
| Q4 24 | $8.3M | $15.6M | ||
| Q3 24 | $19.5M | $11.0M | ||
| Q2 24 | $13.7M | $1.0M | ||
| Q1 24 | $6.6M | $11.2M |
自由现金流KRTPBYI
| Q4 25 | $15.1M | $14.4M | ||
| Q3 25 | $736.0K | $9.7M | ||
| Q2 25 | $9.6M | $14.1M | ||
| Q1 25 | $7.6M | $3.6M | ||
| Q4 24 | $8.0M | $15.6M | ||
| Q3 24 | $19.2M | $11.0M | ||
| Q2 24 | $13.4M | $1.0M | ||
| Q1 24 | $6.4M | — |
自由现金流率KRTPBYI
| Q4 25 | 13.1% | 19.1% | ||
| Q3 25 | 0.6% | 17.7% | ||
| Q2 25 | 7.7% | 26.8% | ||
| Q1 25 | 7.4% | 7.7% | ||
| Q4 24 | 7.9% | 26.4% | ||
| Q3 24 | 17.0% | 13.7% | ||
| Q2 24 | 11.9% | 2.1% | ||
| Q1 24 | 6.7% | — |
资本支出强度KRTPBYI
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.2% | 0.0% | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 0.2% | 0.0% | ||
| Q1 24 | 0.2% | 0.0% |
现金转化率KRTPBYI
| Q4 25 | 2.26× | — | ||
| Q3 25 | 0.13× | 1.10× | ||
| Q2 25 | 0.89× | 2.41× | ||
| Q1 25 | 1.21× | 1.21× | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 2.14× | 0.54× | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 1.06× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
